| Abstrakt: |
A recent study conducted at Santa Chiara Hospital in Italy analyzed the survival, treatment duration, and costs of patients with prostate cancer treated with triptorelin. The study included 3,411 patients and found that both overall survival and duration of treatment were not reached in the groups analyzed. The research highlighted the long-term efficacy of triptorelin treatment in Italian patients with prostate cancer, emphasizing the importance of integrating results from clinical studies with real-world clinical practice. [Extracted from the article] |
